CHE (STOCKS)
Chemed Corporation
$381.042400
-6.577600 (-1.70%)
Prev close: $387.620000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Hospital/Nursing Management
- CEO
- Kevin J. McNamara
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,181.33M
- Employees
- 15,695
- P/E (TTM)
- 21.13
- P/B (TTM)
- 5.43
- Dividend Yield
- 59.34%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
2
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$6.42 | $7.14 | -0.7182 | -10.06% |
|
Sep 2025 (Q3)
|
$5.27 | $5.43 | -0.1562 | -2.88% |
|
Jun 2025 (Q2)
|
$4.27 | $5.03 | -0.7598 | -15.11% |
|
Mar 2025 (Q1)
|
$5.63 | $5.60 | +0.0279 | +0.50% |
Financial Statements
| Revenues | $2.53B |
| Benefits Costs and Expenses | $2.17B |
| Cost Of Revenue | $1.71B |
| Costs And Expenses | $2.19B |
| Gross Profit | $823.18M |
| Nonoperating Income/Loss | $19.28M |
| Operating Expenses | $2.19B |
| Selling, General, and Administrative Expenses | $417.19M |
| Other Operating Expenses | $1.77B |
| Operating Income/Loss | $338.25M |
| Income/Loss From Continuing Operations After Tax | $265.24M |
| Income/Loss From Continuing Operations Before Tax | $355.78M |
| Income Tax Expense/Benefit | $90.54M |
| Income Tax Expense/Benefit, Deferred | -$5.94M |
| Interest Expense, Operating | $1.75M |
| Net Income/Loss | $265.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $265.24M |
| Net Income/Loss Available To Common Stockholders, Basic | $265.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $18.42 |
| Diluted Earnings Per Share | $18.34 |
| Basic Average Shares | 14,398,000 |
| Diluted Average Shares | 14,460,000 |
| Common Stock Dividends | $2.20 |
| Assets | $1.54B |
| Current Assets | $302.62M |
| Inventory | $7.54M |
| Other Current Assets | $295.07M |
| Noncurrent Assets | $1.24B |
| Fixed Assets | $205.66M |
| Intangible Assets | $82.76M |
| Other Non-current Assets | $947.15M |
| Liabilities | $558.78M |
| Current Liabilities | $287.13M |
| Accounts Payable | $64.46M |
| Wages | $58.33M |
| Other Current Liabilities | $164.34M |
| Noncurrent Liabilities | $271.65M |
| Equity | $979.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $979.41M |
| Liabilities And Equity | $1.54B |
| Net Cash Flow From Operating Activities | $388.27M |
| Net Cash Flow From Operating Activities, Continuing | $388.27M |
| Net Cash Flow From Investing Activities | -$59.34M |
| Net Cash Flow From Investing Activities, Continuing | -$59.34M |
| Net Cash Flow From Financing Activities | -$432.77M |
| Net Cash Flow From Financing Activities, Continuing | -$432.77M |
| Net Cash Flow | -$103.84M |
| Net Cash Flow, Continuing | -$103.84M |
| Comprehensive Income/Loss | $265.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $265.24M |
| Other Comprehensive Income/Loss | $0.00 |